For the Inventor, By the Inventor

Enter assignee name

Berkshire, United Kingdom

Celltech Limited

USPTO Granted Patents = 42

Forward Citations = 3,066

Loading Chart...

Loading Chart...

65 inventors (with patents filed for the assignee):

Thomas A Millican (10 out of 19 patents)

David Parker (6 out of 20 patents)

Peter Anthony Lowe (5 out of 5 patents)

4. Raymond John Owens (4 out of 10 patents)

5. Nigel Robert Beeley (4 out of 11 patents)

6. John Robert Porter (3 out of 66 patents)

7. Michael Anthony Eaton (3 out of 8 patents)

8. John Robert Adair (3 out of 18 patents)

9. Mark William Bodmer (3 out of 12 patents)

10. Geoffrey Thomas Yarranton (3 out of 8 patents)

11. John R Morphy (3 out of 5 patents)

12. Stephen Keith Rhind (3 out of 4 patents)

13. John Spencer Emtage (2 out of 17 patents)

14. Christopher Robert Bebbington (2 out of 10 patents)

15. Susan Mary Kingsman (2 out of 26 patents)

Core Competencies:

Tetra-Aza Macrocycles

Humanized Antibodies

Recombinant DNA Expression Vectors

Peptidyl Derivatives

Multivalent Antigen-Binding Proteins

Antibody Conjugates

Calcitonin Peptides

Monoclonal Antibody

Tri-Aza Macrocycles

C-Terminal CAT Fusion Protein

Thiol-Reactive Cross-Linking Reagents

42 patents: Sort by Forward Citations

1. 6774228 - Tetra-aza macrocycles and metal complexes thereof (2004-08-10),

2. 6509451 - Cross-linked antibodies and processes for their preparation (2003-01-21),

3. 6307026 - Humanized antibodies directed against A33 antigen (2001-10-23),

4. 5965405 - Method for producing Fv fragments in eukaryotic cells (1999-10-12),

5. 5958413 - Use of antibodies to TNF or fragments derived thereof and xanthine (1999-09-28),

6. 5889058 - Peptidyl derivatives (1999-03-30),

7. 5864019 - Multivalent antigen-binding proteins (1999-01-26),

8. 5859205 - Humanised antibodies (1999-01-12),

9. 5858755 - Lipase from human gastric mucosal tissue (1999-01-12),

10. 5691181 - DNA encoding lipase from human gastric mucosal tissue (1997-11-25),

11. 5681718 - Methods for enhanced production of tissue plasminogen activator in cell (1997-10-28),

12. 5658759 - Recombinant DNA expression vectors (1997-08-19),

13. 5591639 - Recombinant DNA expression vectors (1997-01-07),

14. 5569665 - Peptidyl derivatives and their use as metalloproteinases inhibitors (1996-10-29),

15. 5500350 - Binding assay device (1996-03-19),

Celltech Limited is a leading biotechnology company specializing in the research, development, and commercialization of innovative healthcare solutions. With a strong focus on cell therapies and regenerative medicine, Celltech is committed to improving patient outcomes and addressing unmet medical needs. Through strategic collaborations and in-house expertise, Celltech leverages cutting-edge technologies to develop advanced therapies for various diseases. As a responsible corporate citizen, Celltech prioritizes quality, ethics, and social responsibility in all aspects of their operations.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Dec 30 2025

42 Patents

#5 in Berkshire

#404 in United Kingdom

#15,864 in the World

Berkshire, United Kingdom

Celltech Limited

Forward Citations = 3,066

65 inventors:

Thomas A Millican (10 out of 19 patents)

David Parker (6 out of 20 patents)

Peter Anthony Lowe (5 out of 5 patents)

4. Raymond John Owens (4 out of 10 patents)

5. Nigel Robert Beeley (4 out of 11 patents)

Please report any incorrect information to support@idiyas.com

Loading…